companies working on glp-1 drugs FDA says that the shortage is over Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists
Description
This seems counterintuitiveand there are some valid concerns about giving a drug that makes people less hungry to those already consuming too little

[PMC free article] [PubMed] [Google Scholar] 132.Costanzo G., Curatolo S., Bus B., Belfiore A., Gullo D
A sizable minority experience side effects like nausea

These studies showed that tirzepatide not only improved glycemic control but also reduced body weight

Current evidence summary In 11 lactating women given 5 mg subcutaneous tirzepatide, 95.9 percent of milk samples showed undetectable levels

Bloating and Constipation on GLP-1s Bloating and constipation are the two most common digestive complaints on GLP-1s, and they usually trace back to the same root cause: slower transit